Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,772 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
Oikawa S, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan. Oikawa S, et al. Among authors: saito y. Atherosclerosis. 2009 Oct;206(2):535-9. doi: 10.1016/j.atherosclerosis.2009.03.029. Epub 2009 Apr 5. Atherosclerosis. 2009. PMID: 19447387 Clinical Trial.
Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison.
Saito Y, Yamada N, Teramoto T, Itakura H, Hata Y, Nakaya N, Mabuchi H, Tushima M, Sasaki J, Goto Y, Ogawa N. Saito Y, et al. Arzneimittelforschung. 2002;52(4):251-5. doi: 10.1055/s-0031-1299888. Arzneimittelforschung. 2002. PMID: 12040967 Clinical Trial.
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, Sasaki J; Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Hata Y, et al. Among authors: saito y. J Atheroscler Thromb. 2002;9(1):1-27. doi: 10.5551/jat.9.1. J Atheroscler Thromb. 2002. PMID: 12238634 Free article.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.
Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial. Matsuzaki M, et al. Among authors: saito y. Circ J. 2002 Dec;66(12):1087-95. doi: 10.1253/circj.66.1087. Circ J. 2002. PMID: 12499611 Free article.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial. Mabuchi H, et al. Among authors: saito y. Circ J. 2002 Dec;66(12):1096-100. doi: 10.1253/circj.66.1096. Circ J. 2002. PMID: 12499612 Free article.
Preventing angiographic progression of coronary atherosclerosis with pravastatin.
Daida H, Ouchi Y, Saito Y, Yamada N, Nishide T, Mokuno H, Kurata T, Sato H, Eto M, Ako JY, Tango T, Yamaguchi H; Coronary Atherosclerosis and Lipid Research Group. Daida H, et al. Among authors: saito y. J Atheroscler Thromb. 2003;10(1):25-31. doi: 10.5551/jat.10.25. J Atheroscler Thromb. 2003. PMID: 12621161 Free article. Clinical Trial.
9,772 results